Intraosseous basivertebral nerve ablation: Pooled long-term outcomes from two prospective clinical trials

Abstract

Intraosseous BVNA demonstrates statistically significant, clinically meaningful, and durable improvements in pain and function through 3 years in patients with primary vertebrogenic low back pain. BVNA-treated patients significantly reduced opioid use and interventions for low back pain.